top of page

KGI’s Dr. Kiana Aran Receives NIH Funding to Help Set Quality Control Standards for CRISPR Therapies

Updated: Jan 7


Dr. Kiana Aran, Associate Professor of Medical Diagnostics and Therapeutics and head of the Aran Lab at Keck Graduate Institute (KGI) and Chief Scientific Officer of Cardea Bio, was recently selected for a significant grant from the National Institutes of Health (NIH). This grant helps develop CRISPR Quality Control standards for therapeutics applications in this groundbreaking area of science, starting with a focus on Sickle Cell Disease. The award covers 1.63 million dollars in funding over four years.

15 views0 comments

Recent Posts

See All

We are thrilled to share that our CRISPR-Chip, the backbone of our CRISPR Analytics Platform, is now being showcased at the German DHMD museum in Dresden as part of the esteemed exhibition 'Of Genes a

bottom of page